"Not a single country took advantage of the waiver for IP protections to increase the supply of vaccines....I fear we're creating a precedent that will weaken the U.S. innovation economy, which is so important if we want to look at developing cures for some of the most dreaded diseases out there." - Gary Locke
In a webinar hosted today by the Council for Innovation Promotion (C4IP), the organization's founders, Andrei Iancu and David Kappos, both former Directors of the U.S. Patent and Trademark Office (USPTO), spoke with former U.S. Secretary of Commerce, Gary Locke, about the increased skepticism surrounding a plan to extend the waiver of intellectual property protections for COVID-19 vaccines under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to COVID-19 diagnostics and therapeutics.
In a webinar hosted today by the Council for Innovation Promotion (C4IP), the organization's founders, Andrei Iancu and David Kappos, both former Directors of the U.S. Patent and Trademark Office (USPTO), spoke with former U.S. Secretary of Commerce, Gary Locke, about the increased skepticism surrounding a plan to extend the waiver of intellectual property protections for COVID-19 vaccines under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to COVID-19 diagnostics and therapeutics.
#people #united-states #development #biden-administration #white-house #distribution #vice-president #switzerland #involvement #million-doses
[
add
]
[
|
|
...
]